• 1. Richardson DW. The metacarpophalangeal joint. In: Ross MW, Dyson SJ, eds. Diagnosis and management of lameness in the horse. St Louis: Saunders, 2003; 348362.

    • Search Google Scholar
    • Export Citation
  • 2. Spike-Pierce DL, Bramlage LR. Correlation of racing performance with radiographic changes in the proximal sesamoid bones of 487 Thoroughbred yearlings. Equine Vet J 2003; 35: 350353.

    • Search Google Scholar
    • Export Citation
  • 3. McCarrel T & Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res 2009; 27: 10331042.

    • Search Google Scholar
    • Export Citation
  • 4. Schnabel LV, Sonea HO, Jacobson MS, et al. Effects of platelet rich plasma and acellular bone marrow on gene expression patterns and DNA content of equine suspensory ligament explant cultures. Equine Vet J 2008; 40: 260265.

    • Search Google Scholar
    • Export Citation
  • 5. Schnabel LV, Mohammed HO, Miller BJ, et al. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res 2007; 25: 230240.

    • Search Google Scholar
    • Export Citation
  • 6. Smith JJ, Ross MW, Smith RKW. Anabolic effects of acellular bone marrow, platelet rich plasma, and serum on equine suspensory ligament fibroblasts in vitro. Vet Comp Orthop Traumatol 2006; 19: 4347.

    • Search Google Scholar
    • Export Citation
  • 7. Lyras DN, Kazakos K, Verettas D, et al. The effect of platelet-rich plasma gel in the early phase of patellar tendon healing. Arch Orthop Trauma Surg 2009; 129: 15771582.

    • Search Google Scholar
    • Export Citation
  • 8. Spang JT, Tischer T, Salzmann GM, et al. Platelet concentrate vs. saline in a rat patellar tendon healing model. Knee Surg Sports Traumatol Arthrosc 2011; 19: 495502.

    • Search Google Scholar
    • Export Citation
  • 9. Bosch G, Moleman M, Barneveld A, et al. The effect of platelet-rich plasma on the neovascularization of surgically created equine superficial digital flexor tendon lesions. Scand J Med Sci Sports 2011; 21: 554561.

    • Search Google Scholar
    • Export Citation
  • 10. Bosch G, van Schie HTM, de Groot MW, et al. Effects of platelet-rich plasma on the quality of repair of mechanically induced core lesions in equine superficial digital flexor tendons: a placebo-controlled experimental study. J Orthop Res 2010; 28: 211217.

    • Search Google Scholar
    • Export Citation
  • 11. Argüelles D, Carmona JU, Climent F, et al. Autologous platelet concentrates as a treatment for musculoskeletal lesions in five horses. Vet Rec 2008; 162: 208211.

    • Search Google Scholar
    • Export Citation
  • 12. Waselau M, Sutter WW, Genovese RL, et al. Intralesional injection of platelet-rich plasma followed by controlled exercise for treatment of midbody suspensory ligament desmitis in Standardbred racehorses. J Am Vet Med Assoc 2008; 232: 15151520.

    • Search Google Scholar
    • Export Citation
  • 13. Mishra A & Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 2006; 34: 17741778.

  • 14. Peerbooms JC, Sluimer J, Bruijn DJ, et al. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med 2010; 38: 255262.

    • Search Google Scholar
    • Export Citation
  • 15. de Vos RJ, Weir A, Tol JL, et al. No effects of PRP on ultrasonographic tendon structure and neovascularisation in chronic mid-portion Achilles tendinopathy. Br J Sports Med 2011; 45: 387392.

    • Search Google Scholar
    • Export Citation
  • 16. de Vos RJ, Weir A, van Schie HTM, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA 2010; 303: 144149.

    • Search Google Scholar
    • Export Citation
  • 17. Cheetham J, Riordan AS, Mohammed HO, et al. Relationships between race earnings and horse age, sex, gait, track surface and number of race starts for Thoroughbred and Standardbred racehorses in North America. Equine Vet J 2010; 42: 346350.

    • Search Google Scholar
    • Export Citation
  • 18 The Jockey Club. 2011 online fact book. Available at: www.jockeyclub.com/factbook.asp. Accessed Feb 27, 2012.

  • 19. Textor JA, Norris JW & Tablin F. Effects of preparation method, shear force, and exposure to collagen on release of growth factors from equine platelet-rich plasma. Am J Vet Res 2011; 72: 271278.

    • Search Google Scholar
    • Export Citation

Injection of platelet- and leukocyte-rich plasma at the junction of the proximal sesamoid bone and the suspensory ligament branch for treatment of yearling Thoroughbreds with proximal sesamoid bone inflammation and associated suspensory ligament branch desmitis

Katherine S. Garrett DVM, DACVS1, Lawrence R. Bramlage DVM, MS, DACVS2, Deborah L. Spike-Pierce DVM3, and Noah D. Cohen VMD, PhD, DACVIM4
View More View Less
  • 1 Rood and Riddle Equine Hospital, PO Box 12070, Lexington, KY 40580
  • | 2 Rood and Riddle Equine Hospital, PO Box 12070, Lexington, KY 40580
  • | 3 Rood and Riddle Equine Hospital, PO Box 12070, Lexington, KY 40580
  • | 4 Department of Large Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843 (Cohen).

Abstract

Objective—To determine the effects of treatment with platelet- and leukocyte-rich plasma (PRP) on future 2-, 3-, and 4-year-old racing performance of yearling Thoroughbreds with proximal sesamoid bone inflammation and associated suspensory ligament branch (SLB) desmitis.

Design—Randomized clinical trial.

Animals—39 yearling Thoroughbreds.

Procedures—Yearling Thoroughbreds with radiographic evidence of performance-limiting proximal sesamoid bone inflammation and ultrasonographic evidence of associated SLB desmitis were identified and randomly assigned to undergo PRP (treatment group) or saline (0.9% NaCl) solution (control group) injection at the affected SLB-proximal sesamoid bone junction. Race records of horses for the 2-, 3-, and 4-year-old racing years were obtained. Data regarding amount of money earned and number of races started were used as outcome measures, and results for groups were compared.

Results—Horses treated with PRP were significantly more likely to start at least 1 race during the 2-year-old racing year than were horses treated with saline solution; no significant differences were detected between groups regarding that variable for the 3- and 4-year-old racing years. No significant differences between groups were detected regarding earnings for any racing year.

Conclusions and Clinical Relevance—Although PRP-treated horses were more likely to start a race during the 2-year-old racing year versus control group horses, results for horses in each group were not significantly different for the 3- and 4-year-old racing years. Therefore, the PRP treatment protocol evaluated in this study did not seem to improve future racing performance of yearling Thoroughbreds with proximal sesamoid bone inflammation and associated SLB desmitis, compared with injection of saline solution.

Abstract

Objective—To determine the effects of treatment with platelet- and leukocyte-rich plasma (PRP) on future 2-, 3-, and 4-year-old racing performance of yearling Thoroughbreds with proximal sesamoid bone inflammation and associated suspensory ligament branch (SLB) desmitis.

Design—Randomized clinical trial.

Animals—39 yearling Thoroughbreds.

Procedures—Yearling Thoroughbreds with radiographic evidence of performance-limiting proximal sesamoid bone inflammation and ultrasonographic evidence of associated SLB desmitis were identified and randomly assigned to undergo PRP (treatment group) or saline (0.9% NaCl) solution (control group) injection at the affected SLB-proximal sesamoid bone junction. Race records of horses for the 2-, 3-, and 4-year-old racing years were obtained. Data regarding amount of money earned and number of races started were used as outcome measures, and results for groups were compared.

Results—Horses treated with PRP were significantly more likely to start at least 1 race during the 2-year-old racing year than were horses treated with saline solution; no significant differences were detected between groups regarding that variable for the 3- and 4-year-old racing years. No significant differences between groups were detected regarding earnings for any racing year.

Conclusions and Clinical Relevance—Although PRP-treated horses were more likely to start a race during the 2-year-old racing year versus control group horses, results for horses in each group were not significantly different for the 3- and 4-year-old racing years. Therefore, the PRP treatment protocol evaluated in this study did not seem to improve future racing performance of yearling Thoroughbreds with proximal sesamoid bone inflammation and associated SLB desmitis, compared with injection of saline solution.

Contributor Notes

Supported in part by Biomet Inc.

Presented as a podium presentation at the 2010 American College of Veterinary Surgeons Symposium, Seattle, October 2010.

Address correspondence to Dr. Garrett (kgarrett@roodandriddle.com).